-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KNiNUZ1WKaYqOQ4G0LrrxQkY4wqqqXV3G13YQFE0GzS1aOmVgj/f9iE0/YmicQ+9 Lk8HFKlXExcRcZH6AvSxMg== 0001237899-10-000052.txt : 20101220 0001237899-10-000052.hdr.sgml : 20101220 20101220183139 ACCESSION NUMBER: 0001237899-10-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101216 FILED AS OF DATE: 20101220 DATE AS OF CHANGE: 20101220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MURRAY A CENTRAL INDEX KEY: 0001226435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 101263934 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-12-16 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226435 GOLDBERG MURRAY A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP F&A, CFO, Treas & Asst Sec Common Stock 2010-12-16 4 M 0 16250 13 A 59984 D Common Stock 2010-12-16 4 F 0 6642 31.8 D 53342 D Common Stock 2010-12-16 4 F 0 4440 31.8 D 48902 D Common Stock 2010-12-17 4 S 0 5168 32.15 D 43734 D Common Stock 5136 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 13 2010-12-16 4 M 0 16250 D 2013-12-15 Common Stock 16250 16058 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 5,168 shares of Company stock on December 17, 2010 at prices ranging from $31.81 to $32.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 17, 2010 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**Murray A. Goldberg 2010-12-20 -----END PRIVACY-ENHANCED MESSAGE-----